Medical News

RSS

Health IT Blotter: Extension center choices, Medicaid meaningful use, 'build or buy' shift

The U.S. Department of Health and Human Services has selected the final two of 62 regional extension centers (REC), which will help small, rural hospitals and private physicians with the nationwide rollout of electronic medical records (EMR) systems.

30 Sep 2010

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute's Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.

30 Sep 2010

Today's Opinions: Health law leaves children behind; growing fear of accountable care organizations

The child only market is used mostly by poor families who can't afford to insure everybody in their household, or whose peculiar circumstances make it inconvenient for them to cover a child under a parent's plan.

30 Sep 2010

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).

30 Sep 2010

Michigan University researchers receive funds to study breast cancer risk factors

A team of researchers led by a Michigan State University scientist has been awarded $14 million to identify risk factors for breast cancer in young women, focusing on growth, diet, physical activity and body size during a woman's lifetime.

30 Sep 2010

Memantine enhances language and communication skills in patients with Alzheimer's disease

Memantine enhances language and communication skills in patients with moderate to severe Alzheimer’s disease (AD), a valuable contribution for patient independence and quality of life for both the patient and the family/caregivers. These are the findings discussed at the 14th Congress of the European Federation of Neurological Societies (EFNS).

30 Sep 2010

Study shows how different body measurements correspond with ratings of female attractiveness

Scientists in Australia and Hong Kong have conducted a comprehensive study to discover how different body measurements correspond with ratings of female attractiveness. The study, published in the Journal of Evolutionary Biology, found that across cultural divides young, tall and long armed women were considered the most attractive.

30 Sep 2010

NEUROKIN accentuates its leadership in the treatment of acute neurological diseases

Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.

29 Sep 2010

Breakthrough neuroblastoma treatment

According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.

29 Sep 2010

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Circadian Technologies (ASX.CIR) has announced today that it has partnered with Cincinnati Children’s Hospital Medical Centre (CCHMC) to develop and market a blood test to diagnose LAM, a serious lung disease that strikes women, usually in their child bearing years.

29 Sep 2010

Starpharma expands partnership with Eli Lilly

Starpharma Holdings Limited (ASX:SPL,OTCQX:SPHRY) today announced the signing of a collaborative research agreement with leading US pharmaceutical corporation Eli Lilly and Company.

29 Sep 2010

Push to delay Australia’s R&D tax credit will hurt start-up innovators

Much-needed change to Australia’s R&D tax system is amongst legislative bills to be re-introduced to Parliament as it resumes this week. AusBiotech urges MPs to support the swift passage of the R&D Tax Credit legislation and the Government to persist with its introduction.

29 Sep 2010

Unique genetic markers point to patient response to SCV-07 treatment

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that researchers have identified two unique gene clusters that differentiated subjects who responded to treatment in the Company’s phase 2a proof of concept study of SCV-07 for the prevention of severe oral mucositis (OM; WHO grades 3-4) in patients with advanced head and neck cancer.

29 Sep 2010

Congress must stop Medicare cuts in November

The AMA, along with medical societies representing 50 states and the District of Columbia and 65 national physician organizations, united to send a strong message to Congress – immediate action is needed to stop the drastic 30 percent Medicare payment cuts looming at the end of this year to protect seniors’ access to health care.

29 Sep 2010

Social rejection can ‘brake’ your heart

Latest study shows that a social rejection can not only break a person’s heart but also result in a drop in the heart rate. The researchers from Netherlands found that the disappointment of feeling not loved or not liked can cause both psychological and physical reactions.

29 Sep 2010

HIV AIDS drugs’ universal access dream remains improbable: Report

In a disappointing new report jointly commissioned by the World Health Organisation (WHO), the UN's AIDS programme and UNICEF it was revealed that only one third of people worldwide who need life-saving HIV drugs are actually getting treated. Universal access to these medicines has been the theme of effort but it was seen that that targets would not be met. The report urges the poorer countries must “substantially ramp up” the funds for HIV/AIDS.

29 Sep 2010

Swine flu no longer a threat to Americans: Report

According to the latest research most Americans are immune to the swine flu virus. Results of the study by the National Institute of Allergy and Infectious Diseases, published in the journal mBio show that around 59 percent of the 310 million U.S. population has developed immunity to H1N1 either from exposure to similar viruses, vaccination, or natural H1N1 infection.

29 Sep 2010

Malaria vaccine close to reality

A successful and effective malaria vaccine could be available in Africa by 2015 revealed a co-inventor of the shot against the killer disease, Tuesday. Advance trials of the RTS,S vaccine against falciparum malaria are under way in seven African countries. This variety of malaria is the deadliest and trials are said to be showing encouraging results according to GlaxoSmithKline researcher Joe Cohen, who has been working on developing the vaccine for over 20 years.

29 Sep 2010

School blood test breached guidelines: Investigation report

According to a report by an Education Department, a Tasmanian teacher who conducted blood tests on 19 high school students breached guidelines. The incident happened last month when a teacher at the Dover District High School took blood samples from the students using just two lancets for a science class experiment. These lancets were cleaned between pricks using methylated spirits. These spirits are inadequate when preventing blood borne viral disease like HIV and Hepatitis say experts.

29 Sep 2010

Some IVF techniques leading to more bundles in blue: Study

According to a new study by Australian researchers some infertility treatments may influence the sex of a baby to such an extent that increased uptake could upset the gender balance later. The study shows that a type of IVF treatment increases the chance of having a boy to as much as 56.1 per cent, while another treatment cuts it to 48.7 per cent.

29 Sep 2010

Medical News

Health IT Blotter: Extension center choices, Medicaid meaningful use, 'build or buy' shift

UNC scientists receive grant to develop targeted delivery system for pancreatic cancer

Today's Opinions: Health law leaves children behind; growing fear of accountable care organizations

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Michigan University researchers receive funds to study breast cancer risk factors

Memantine enhances language and communication skills in patients with Alzheimer's disease

Study shows how different body measurements correspond with ratings of female attractiveness

NEUROKIN accentuates its leadership in the treatment of acute neurological diseases

Breakthrough neuroblastoma treatment

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Starpharma expands partnership with Eli Lilly

Push to delay Australia’s R&D tax credit will hurt start-up innovators

Unique genetic markers point to patient response to SCV-07 treatment

Congress must stop Medicare cuts in November

Social rejection can ‘brake’ your heart

HIV AIDS drugs’ universal access dream remains improbable: Report

Swine flu no longer a threat to Americans: Report

Malaria vaccine close to reality

School blood test breached guidelines: Investigation report

Some IVF techniques leading to more bundles in blue: Study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News